Europe's largest meeting in applied and translational neuroscience, the 30th ECNP Congress of the European College of Neuropsychopharmacology (ECNP) will take place at the Paris Conference Centre, Paris from 2nd to 5th September 2017. Between 4,000 and 6,000 psychiatrists, neuroscientists, neurologists and psychologists are expected to attend the Paris congress.
The 2016 ECNP congress produced some major press stories (see https:/
- Terror attack and treatment - what should be done?
- Novel approaches to cocaine addiction
- Breaking the link between insomnia and depression
- Exercise and psychiatric disease
- Prevention of mental diseases; the role of treatment in pregnancy
Journalists are welcome to attend the conference, please see: http://2017.
Journalists who cannot attend can still receive advance press releases, by contacting firstname.lastname@example.org During the Congress, you can reach the ECNP press officer, Tom Parkhill, on the above email or via +39 349 238 8191.
The congress website is: http://2017.
ECNP is an independent scientific association committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health. The annual ECNP Congress attracts scientists and clinicians from across the world to discuss the latest advances in brain research at Europe's premier showcase for new research, treatment and technology in applied brain research. More information about ECNP, its aims and activities, can be found at http://www.